Belantamab (Anti-TNFRSF17 / BCMA / CD269)

Ask supplier a question | View on supplier's website

Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2328
Sku #	A2328-1mg
Pricing	1mg, $370.00

Feedback